BioSpace News Archive

Upgrade Program Enables Customers to Access Newest MR Innovations Without the Costs Associated with a New Installation

uarterly dividend of $0.21 per share, payable on September 17, 2019 to shareholders of record on August 30, 2019.

PK Papyrus Stent Delivers Emergency Treatment for Acute Coronary Artery Perforations

Judge Jeanine is the host of Fox News Channel’s top-rated “Justice with Judge Jeanine” and a frequent guest on other primetime shows.

Report entitled “Sucking Wind” outlines how Penumbra faces 40-55% downside risk to approximately $85.00 to $110.00 per share after accounting for a wave of new competition, deeply misunderstood market share loss, pricing pressure and a contracting valuation premium as growth slows.

Baylor St. Luke’s Medical Center has been recognized as a Best Hospital for 2019-2020 according to U.S. News & World Report, including second in Houston and third in Texas.

TrialScoutTM, the only ratings and reviews platform where patients can directly share their experience in clinical trials, is proud to recognize the elite clinical research programs driving American healthcare forward by awarding the first ever Excellence in Clinical Research Top 50 Hospitals of 2019.

Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, today announced it has successfully completed a U.S. Food and Drug Administration (FDA) regulatory review of its Oleena™ software for oncology-related symptoms management and remote patient monitoring. Oleena™ is determined as Class II medical device falling under enforcement discretion per FDA Guidance.

Women with preeclampsia are most vulnerable to complications

Vendors in the market are increasingly focusing on the adoption of more targeted approaches such as anabolic medications for the effective treatment of the disease.